IW | Blood-Brain Barrier and Epilepsy: Latest Advances

Sunday, December 6, 2026 at 10:30 AM to 12:00 PM · 1 hr. 30 min. (America/Denver)
Investigators Workshop

Information

The objective in this Investigator Workshop is to explore the cellular and molecular targets at the blood-brain barrier in epilepsy for potentially regulating seizures, epileptogenesis, and improving drug efficacy. We discuss multimodular approaches of relevance of endocannabinoid signaling, glucocorticoid receptor, aquaporins, and neuroinflammatory modulators from pre-clinical seizure models to people with epilepsy in the context of how to better manage seizures and alleviate neurovascular dysfunction.
Learning Objective 1
Examine endocannabinoid signaling at the blood-brain barrier and its influence on seizure and epilepsy
Learning Objective 2
Review how blood-brain barrier glucocorticoid receptor influences molecular regulators in the pharmacoresistant epilepsy and recognize the role of aquaporins in temporal lobe epilepsy
Learning Objective 3
Discuss the role of blood-brain barrier post-traumatic brain injury and consequences of neuroinflammation and neuromodulation during epileptogenesis
Target Audience
CliniciansFellows/TraineesAdvocatesBehavioral Health ProvidersCommunity Health WorkersPharmacistsScientists/ResearchersSocial WorkersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session Content Includes
and Inclusion (DEI)DiversityEquityPediatric
Session ID
BARRIERIW26
Presentation Id
3451949
Event ID
24056
Session Type
Session